Key Metrics 
Check Before You Invest 
10 Yrs X-Ray 
Valuation 
Analyst Note 
Qtr. Results 
Financials 
News 
About
Veerhealth Care Ltd (NIYATILEAS)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 511523 NSE: NIYATILEAS Trading | Small Cap | Veerhealth Care Share Price
₹49.85 -0.04 (-0.08%)
As on 01-Sep'26 16:59
Veerhealth Care Ltd (NIYATILEAS)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 511523 NSE: NIYATILEAS Trading | Small Cap | Veerhealth Care Share Price
₹49.85 -0.04 (-0.08%)
As on 01-Sep'26 16:59
Key Metrics
Valuation Multiples
Market Cap
₹101 Cr.
Current Price
₹49.9
52-Week Low / High
₹17 / 52
TTM EPS
₹0.8
TTM Sales
₹52.9 Cr.
Book Value per Share
₹12.1
P/E Ratio
66.30
Higher than its 5-year historical median
Industry PE
40.7
Price to Book (P/B)
4.20
Higher than its 5-year historical median
Price to Sales (P/S)
1.91
In line with its 5-year historical median
EV/EBITDA
22.36
Higher than its 5-year historical median
Dividend Yield
0%
Profitability Efficiency
Return on Equity (ROE)
1.78%
Underperforms industry median
Return on Capital Employed (ROCE)
3.15%
Underperforms industry median
Return on Assets (ROA)
1.26%
Operating Profit Margin
2.8%
Net Profit Margin
2.35%
Gross Profit Margin
8.5%
Growth Momentum
1-yr vs 3-yr growth
1-yr vs 3-yr growth
Sales Growth (1 Year)
Improving versus 3-year growth rate
26.1%
Operating Profit Growth (1 Year)
-
-24.59%
Net Profit Growth (1 Year)
-
-4.88%
Asset Quality
Promoter Holding
31.91%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹4 Cr.
Equity
₹20 Cr.
Face Value
₹10
All Time Low / High
₹0.25 / 51.84
Check Before You Invest
Quality
Not GoodValuation
OvervaluedCheck Valuation charts
Price Trend
Weak
Is Veerhealth Care Ltd a good quality company?
Veerhealth Care Ltd is a weak quality company, based on a inconsistent multi-year financial track record.
This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.
We have analysed the performance of the company on the following:
-
How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
-
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
-
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.
How does Veerhealth Care Ltd performance compare with that of its Peers?
Revenue growth of Veerhealth Care Ltd vs industry peers?
Veerhealth Care Ltd revenue CAGR is 7.28%, compared to the industry median CAGR of 1.36%, indicating faster growth and gaining its market share.
Promoter shareholding and pledge status of Veerhealth Care Ltd?
Promoters hold 31.91% of the Veerhealth Care Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Stock return of Veerhealth Care Ltd over the last decade?
Over the last 9 year(s), the stock has delivered a CAGR of 23.8% based on the current price.
10 Year X-Ray :
Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year endData adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
What is a Financial Track Record? How to read this chart in order to understand the data present here?
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Veerhealth Care Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good
Value Creation ⓘ
| Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % ⓘ | 1.1% | 1% | 2.4% | 2.9% | 5.5% | 5% | 2.2% | 6.3% | 6% | 3.2% | - |
| Value Creation Index ⓘ | -0.9 | -0.9 | -0.8 | -0.8 | -0.6 | -0.7 | -0.9 | -0.6 | -0.6 | -0.8 | - |
Growth Parameters ⓘ |
|||||||||||
| Sales ⓘ | 2.1 | 1.9 | 5.2 | 6 | 11.7 | 10.6 | 9.6 | 13.3 | 13.2 | 16.7 | 53 |
| Sales YoY Gr. | - | -9.4% | 169.3% | 15.7% | 96.2% | -9.8% | -9% | 37.8% | -0.4% | 26.1% | - |
| Adj EPS ⓘ | 0 | 0 | 0.1 | 0.1 | 0.2 | 0.3 | -0.1 | 0.8 | 0.2 | 0.2 | 0.8 |
| YoY Gr. | - | 100% | 400% | 10% | 109.1% | 17.4% | -118.5% | NA | -74.7% | 0% | - |
| BVPS (₹) ⓘ | 9.2 | 9.3 | 9.5 | 9.6 | 9.9 | 10.1 | 10.1 | 10.7 | 10.9 | 11.1 | 12.1 |
| Adj Net Profit ⓘ | 0 | 0 | 0.1 | 0.2 | 0.3 | 0.4 | -0.1 | 1.6 | 0.4 | 0.4 | 2 |
| Cash Flow from Ops. ⓘ | -0 | 1.7 | 1.8 | 2 | -0.4 | 1 | 1.8 | -0.7 | 2.9 | -0.4 | - |
| Debt/CF from Ops. ⓘ | -3604 | -0.1 | 0.7 | 0.5 | -7 | 1.7 | 0 | 0 | 0 | -12.5 | - |
CAGR ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | 25.8% | 7.3% | 20.1% | 26.1% | ||||
| Adj EPS ⓘ | 39.5% | -2.8% | NA | 0% | ||||
| BVPSⓘ | 2.1% | 2.3% | 3.4% | 1.7% | ||||
| Share Price | 23.8% | 53.2% | 32.9% | 155.8% | ||||
Key Financial Parameters ⓘ
| Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity % ⓘ | 0.1 | 0.2 | 1.1 | 1.2 | 2.4 | 2.7 | -0.5 | 9 | 1.9 | 1.8 | 6.6 |
| Op. Profit Mgn % ⓘ | -1 | -18.9 | -2.4 | 7.4 | 5.8 | -0.6 | -8.6 | 3.7 | 4.6 | 2.8 | 8.3 |
| Net Profit Mgn % ⓘ | 0.4 | 1.2 | 2.7 | 2.6 | 2.7 | 3.6 | -0.8 | 11.9 | 3.1 | 2.4 | 2.9 |
| Debt to Equity ⓘ | 0.1 | -0 | 0.1 | 0.1 | 0.2 | 0.1 | 0 | 0 | 0 | 0.2 | - |
| Working Cap Days ⓘ | 1,943 | 2,072 | 685 | 525 | 262 | 305 | 348 | 259 | 353 | 313 | 64 |
| Cash Conv. Cycle ⓘ | 274 | 374 | 125 | 42 | 18 | 64 | 75 | 71 | 90 | 68 | 29 |
Valuation of Veerhealth Care - Standalone
Analyst's Notes
No data found!
Management X-Ray
Shareholding Pattern
Promoter's Holding & Share Pledging
| Pledged * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
* Pledged shares as % of Promoter's holding (%)
Financials
| PARTICULARS | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2 | 2 | 5 | 6 | 12 | 11 | 10 | 13 | 13 | 17 |
| Operating Expenses ⓘ + | 2 | 2 | 5 | 6 | 11 | 11 | 10 | 13 | 13 | 16 |
| Operating Profit ⓘ | -0 | -0 | -0 | 0 | 1 | -0 | -1 | 0 | 1 | 0 |
| Operating Profit Margin (%) | -1.0% | -18.9% | -2.4% | 7.4% | 5.8% | -0.6% | -8.6% | 3.7% | 4.6% | 2.8% |
| Other Income ⓘ + | 0 | 1 | 1 | 0 | 0 | 1 | 2 | 1 | 1 | 1 |
| Interest ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 |
| Profit Before Tax ⓘ | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 1 |
| Tax ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 1 | 0 |
| Profit After Tax | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 2 | 0 | 0 |
| PAT Margin (%) | 0.4% | 1.2% | 2.7% | 2.6% | 2.7% | 3.6% | -0.8% | 11.9% | 3.1% | 2.4% |
| Adjusted EPS (₹) | 0.0 | 0.0 | 0.1 | 0.1 | 0.2 | 0.3 | -0.1 | 0.8 | 0.2 | 0.2 |
| Dividend Payout Ratio (%) | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| PARTICULARS | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
Equity and Liabilities | |||||||||||
| Shareholders Fund + | 13 | 13 | 13 | 13 | 14 | 14 | 14 | 21 | 22 | 22 | |
| Debt + | 1 | -0 | 1 | 1 | 2 | 2 | 0 | 0 | 0 | 5 | |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Trade Payables | 0 | 0 | 0 | 2 | 1 | 1 | 2 | 1 | 2 | 3 | |
| Others Liabilities ⓘ | 0 | 0 | 0 | 0 | 1 | 2 | 4 | 3 | 4 | 4 | |
| Total Liabilities ⓘ | 14 | 13 | 15 | 16 | 18 | 19 | 20 | 25 | 28 | 34 | |
Fixed Assets | |||||||||||
| Net Fixed Assets ⓘ + | 3 | 3 | 6 | 5 | 9 | 9 | 11 | 12 | 12 | 20 | |
| CWIP ⓘ | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Investments ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Inventories | 1 | 2 | 1 | 1 | 1 | 2 | 2 | 3 | 1 | 2 | |
| Trade Receivables | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 4 | 3 | |
| Cash Equivalents | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 0 | 1 | |
| Others Assets ⓘ | 9 | 8 | 7 | 7 | 6 | 6 | 6 | 5 | 11 | 7 | |
| Total Assets ⓘ | 14 | 13 | 15 | 16 | 18 | 19 | 20 | 25 | 28 | 34 | |
| PARTICULARS | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow From Operating Activity ⓘ + | -0 | 2 | 2 | 2 | -0 | 1 | 2 | -1 | 3 | -0 |
| Cash Flow From Investing Activity ⓘ + | -0 | -0 | -3 | -2 | -2 | -0 | -1 | -2 | -0 | -8 |
| Cash Flow From Financing Activity ⓘ + | 0 | -1 | 1 | 0 | 2 | -1 | -0 | 6 | -6 | 10 |
| Net Cash Flow ⓘ | -0 | -0 | 0 | 0 | -0 | 0 | 0 | 3 | -3 | 1 |
| PARTICULARS | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ratios | ||||||||||
| ROE (%) | 0.07 | 0.18 | 1.06 | 1.2 | 2.35 | 2.73 | -0.53 | 8.94 | 1.88 | 1.78 |
| ROCE (%) | 1.13 | 1 | 2.38 | 2.89 | 5.5 | 4.97 | 2.17 | 6.32 | 5.96 | 3.15 |
| Asset Turnover Ratio | 0.15 | 0.14 | 0.37 | 0.39 | 0.69 | 0.58 | 0.5 | 0.58 | 0.5 | 0.54 |
| PAT to CFO Conversion(x) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -0.5 | N/A | N/A |
| Working Capital Days | ||||||||||
| Receivable Days | 152.40 | 142.10 | 53.90 | 50.70 | 26.10 | 42.80 | 58.50 | 46.50 | 79.50 | 78 |
| Inventory Days | 133.20 | 252.50 | 87.40 | 54.30 | 32.20 | 49.90 | 71.80 | 65 | 55.20 | 42.10 |
| Payable Days | 37.30 | 46.60 | 20.10 | 84.80 | 55.80 | 42.60 | 85.30 | 56.80 | 54.20 | 76.40 |
Top 5 Mutual Funds Holding
Last Visited Stocks
Announcements
Veerhealth Care Ltd FAQs
The current trading price of Veerhealth Care on 01-Sep-2026 16:59 is ₹49.85.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Aug-2026 the market cap of Veerhealth Care stood at ₹101.3 Cr
The latest P/E ratio of Veerhealth Care as of 31-Aug-2026 is 66.30.
The latest P/B ratio of Veerhealth Care as of 31-Aug-2026 is 4.20.
The 52-week high of Veerhealth Care is ₹51.84 and the 52-week low is ₹16.70.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Veerhealth Care is ₹52.92 ( Cr.) .
Past 10 year’s financial track record analysis by Moneyworks4me indicates that Veerhealth Care Ltd is a below average quality company.
The key valuation ratios of Veerhealth Care Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.
The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Veerhealth Care Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.
About Veerhealth Care Ltd
Veerhealth Care (Formerly known as Niyati Industries) was originally incorporated on July 10, 1992 as Niyati Leasing Limited. From July 15, 1993 the Company had begun the business in the field of Investment and Finance.
In 2013, the management of the company decided to diversify the business activities and changed its main object to Pharma sector and new name of the company is VeerHealth Care. In 2020, the company started operations in cosmetic manufacturing.
The company produces Intensive research based quality products with Expert guidance and enormous experience of renowned Vaid of Mumbai, Dr. Vinod C. Mehta, an Ayurvedic practioner since 30 years and Dr. Rajiv Bhirud, anexpert in formulations of cosmetic and personal care products.
The company is well-equipped with state-of-the-art manufacturing facilities and skilled personnel to ensure optimum utilization of resources with the best quality product.
Business area of the company
The company is engaged in the business of trading and manufacturing and marketing research-based Ayurvedic medicines.
Products of the company
- Skincare
- Bodycare
- Haircare
- Fragrances
- Healthcare
- Oralcare
- Mens Care
- Gifting
- Combos
- Accessories
Certifications
- Ayurvedic Mfg Lic
- Ayurvedic Gmp
- Cosmetic Mfg Lic
- Cosmetic Gmp
- ISO 9001:2015
- AEO Certificate
You have 48 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
